Treatment and outcome of IgA nephropathy in children from one single center experience
Abstract Background There is no standard recommendation for IgA nephropathy treatment in children. Methods This is a retrospective study. From 2012 to 2020, newly diagnosed primary IgAN followed up for at least 1 year were enrolled. The correlation of MESTC scores and clinical index including protei...
Main Authors: | Youying Mao, Wei Zhou, Zhengyu Zhou, Chenxing Zhang, Jiayao Shen, Lei Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-023-04195-8 |
Similar Items
-
Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group
by: Aysegul Oruc, et al.
Published: (2024-12-01) -
Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study
by: Yan Li, et al.
Published: (2022-12-01) -
Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials
by: Zheng Zhang, et al.
Published: (2019-08-01) -
Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary
by: Hirokazu Marumoto, et al.
Published: (2020-09-01) -
Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy
by: Fang Yu, et al.
Published: (2021-01-01)